Oral pulse prednisone therapy after relapse of severe autoimmune chronic active hepatitis: A prospective randomized treatment trial evaluating clinical, biochemical, and lymphocyte subset responses
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 17 (2) , 180-186
- https://doi.org/10.1016/s0168-8278(05)80035-2
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Low–Dose Corticosteroid Therapy After Multiple Relapses of Severe Hbsag–Negative Chronic Active HepatitisHepatology, 1990
- The cellular infiltrate in the liver in auto‐immune chronic active hepatitis: analysis with monoclonal antibodiesLiver International, 1985
- Immune Mechanisms in Autoimmune Chronic Active HepatitisScandinavian Journal of Gastroenterology, 1985
- Complete Resolution of Inflammatory Activity Following Corticosteroid Treatment of HBsAg-Negative Chronic Active Hepatitis†Hepatology, 1984
- Natural History, Clinical Features, and Treatment of Autoimmune HepatitisSeminars in Liver Disease, 1984
- Studies of lymphocyte subpopulations in the liver tissue and blood of patients with chronic active hepatitis (CAH)Journal of Clinical Immunology, 1983
- Relapse Following Treatment Withdrawal in Patients with Autoimmune Chronic Active HepatitisHepatology, 1983
- Effect of Corticosteroids on Suppressor-Cell Activity in Autoimmune and Viral Chronic Active HepatitisNew England Journal of Medicine, 1982
- The characterization and function of human immunoregulatory T lymphocyte subsetsImmunology Today, 1981
- ANTIBODY-DEPENDENT CELL-MEDIATED (K CELL) CYTOTOXICITY AGAINST ISOLATED HEPATOCYTES IN CHRONIC ACTIVE HEPATITISThe Lancet, 1976